The FDA granted the first drug approval for dystrophic epidermolysis bullosa (DEB), a topical gene therapy that treats the blistering wounds it causes, the agency announced Friday. The herpes-simplex virus type 1 vector-based gene therapy,
More News
On Friday, the Gastrointestinal Drugs Advisory Committee voted 12-2 (with two abstentions) that the improvements in liver scarring seen in the pivotal REGENERATE trial with a 25-mg dose of obeticholic acid do not outweigh the various risks,
Eye drops that have been contaminated with a highly drug-resistant strain of bacteria have now been linked to four deaths and 14 cases of blindness, according to an update from the Centers for
Over 60% of participants achieved the weight-reduction target of 20% or higher and had improved body composition in a phase 3 trial of tirzepatide in overweight/obesity.
Officials in Maine have confirmed the first fatal case of the Powassan virus disease in 2023. The Maine Center for Disease Control said Wednesday they found the tick-borne illness in an adult resident from Sagadahoc County.
Major League Baseball launched a community assistance platform Wednesday called “MLB Together.” The platform will focus on youth empowerment; diversity, equity and inclusion; domestic and physical safety;
Search hospitals in Phoenix, AZ that treat Back Surgery (Spinal Fusion) to find the best hospital for you.
When young men pack on excess weight during their teens and 20s, they may inadvertently drive up their risk for prostate cancer later on.